Aminologics Co., Ltd. logo

Aminologics Co., Ltd. (074430)

Market Open
11 Aug, 04:05
KRX SM KRX SM
1,106. 00
+40
+3.7523%
109.78B Market Cap
- P/E Ratio
23.06% Div Yield
98,932 Volume
- Eps
1,066
Previous Close
Add Transaction
Day Range
1,059 1,111
Year Range
855 1,940
Want to track 074430 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

074430 trading today higher at ₩1,106, an increase of 3.7523% from yesterday's close, completing a monthly decrease of -2.6408% or -₩30. Over the past 12 months, 074430 stock lost -16.8421%.
074430 pays dividends to its shareholders, with the most recent payment made on Mar 23, 2022.
Aminologics Co., Ltd. has completed 1 stock splits, with the recent split occurring on Oct 23, 2009.
The company's stock is traded on one exchange.

074430 Chart

People also search for

Fine M-Tec Co., Ltd.
9,090
-0.7642%
Genexine Co., Ltd.
2,715
-0.1838%
TiumBio Co., Ltd.
4,915
-2.2863%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,250
+0.9825%

Aminologics Co., Ltd. (074430) FAQ

What is the stock price today?

The current price is ₩1,106.00.

On which exchange is it traded?

Aminologics Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 074430.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 23.06%.

What is its market cap?

As of today, the market cap is 109.78B.

Has Aminologics Co., Ltd. ever had a stock split?

Aminologics Co., Ltd. had 1 splits and the recent split was on Oct 23, 2009.

Aminologics Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
23 Oct 2009 Last Split
- IPO Date

Overview

Aminologics Co., Ltd. is a forefront biotechnology company based in South Korea, dedicated to the development and production of innovative healthcare solutions. The essence of its operations lies within the biotechnology and pharmaceutical sectors, where it contributes significantly to the advancement of diagnostics and medical treatments. By focusing on creating advanced therapeutic products, Aminologics stands as a pivotal player in the healthcare industry, striving to solve critical health issues and elevate the quality of patient care. This commitment positions Aminologics within a global network of healthcare innovators, relentlessly pushing the boundaries of medical science and technology to improve health outcomes and the quality of life for people worldwide.

Products and Services

Aminologics Co., Ltd. offers a diverse range of products and services geared towards enhancing healthcare through innovation:

  • Advanced Therapeutics: Developing cutting-edge treatments for various diseases, Aminologics is at the forefront of offering novel therapeutic options. These advancements are particularly notable in areas where there is a high unmet medical need, providing hope and potentially life-saving solutions to patients around the globe.
  • Diagnostics: Aminologics contributes significantly to the diagnostics field by creating products that aid in the early detection and monitoring of diseases. These diagnostic solutions play a critical role in healthcare, enabling more effective and tailored treatment plans for patients, thus improving overall treatment outcomes.

Contact Information

Address: -
Phone: -